Study on Lanthanum Carbonate as a Phosphate Binder
Author Information
Author(s): Stephen J.P. Damment
Primary Institution: Shire Pharmaceuticals
Hypothesis
Lanthanum carbonate is more effective than other phosphate binders in reducing phosphate levels in rats.
Conclusion
Lanthanum carbonate is a potent phosphate binder with no observed adverse pharmacological effects.
Supporting Evidence
- Lanthanum carbonate significantly reduced urinary phosphate excretion in rats with normal renal function.
- Aluminum hydroxide showed similar efficacy to lanthanum carbonate in phosphate binding.
- No adverse pharmacological effects were observed in the safety studies conducted.
Takeaway
This study tested a medicine called lanthanum carbonate to see if it helps lower phosphate levels in rats, and it worked well without causing harm.
Methodology
Rats with normal renal function and chronic renal failure were given lanthanum carbonate and other phosphate binders to compare their efficacy in binding phosphate.
Potential Biases
Potential bias due to funding from Shire Pharmaceuticals, the manufacturer of lanthanum carbonate.
Limitations
The study was conducted in animal models, which may not fully represent human responses.
Participant Demographics
Male Sprague Dawley and Wistar rats, aged approximately 8 to 12 weeks.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website